Clinical Trial Update: Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome [Phase 2]

View source ↗

Summary

Clonidine was studied as an adjunct therapy for neonatal abstinence syndrome in a Phase 2 trial that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome

Drugs mentioned

• Clonidine (clonidine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Neonatal Abstinence Syndrome | Phase 2 | Status: COMPLETED